Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Boston Scientific (BSX) jumps as Q4 results exceed analyst expectations
January 31, 2024 6:39 AM ESTBoston Scientific (NYSE: BSX) reported stronger-than-expected results for its fourth quarter, sending its shares 4.3% higher in early New York trading Wednesday.
The company posted adjusted earnings per share (EPS) for the fourth quarter of 55 cents compared to 45 cents year-over-year (YoY), and beating the consensus estimate of 51... More
